Cargando…

Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase

[Image: see text] Norcoclaurine synthase (NCS) is a Pictet-Spenglerase that catalyzes the first key step in plant benzylisoquinoline alkaloid metabolism, a compound family that includes bioactive natural products such as morphine. The enzyme has also shown great potential as a biocatalyst for the fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lichman, Benjamin R., Sula, Altin, Pesnot, Thomas, Hailes, Helen C., Ward, John M., Keep, Nicholas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637010/
https://www.ncbi.nlm.nih.gov/pubmed/28915025
http://dx.doi.org/10.1021/acs.biochem.7b00769
_version_ 1783270559203721216
author Lichman, Benjamin R.
Sula, Altin
Pesnot, Thomas
Hailes, Helen C.
Ward, John M.
Keep, Nicholas H.
author_facet Lichman, Benjamin R.
Sula, Altin
Pesnot, Thomas
Hailes, Helen C.
Ward, John M.
Keep, Nicholas H.
author_sort Lichman, Benjamin R.
collection PubMed
description [Image: see text] Norcoclaurine synthase (NCS) is a Pictet-Spenglerase that catalyzes the first key step in plant benzylisoquinoline alkaloid metabolism, a compound family that includes bioactive natural products such as morphine. The enzyme has also shown great potential as a biocatalyst for the formation of chiral isoquinolines. Here we present new high-resolution X-ray crystallography data describing Thalictrum flavum NCS bound to a mechanism-inspired ligand. The structure supports two key features of the NCS “dopamine-first” mechanism: the binding of dopamine catechol to Lys-122 and the position of the carbonyl substrate binding site at the active site entrance. The catalytically vital residue Glu-110 occupies a previously unobserved ligand-bound conformation that may be catalytically significant. The potential roles of inhibitory binding and alternative amino acid conformations in the mechanism have also been revealed. This work significantly advances our understanding of the NCS mechanism and will aid future efforts to engineer the substrate scope and catalytic properties of this useful biocatalyst.
format Online
Article
Text
id pubmed-5637010
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-56370102017-10-13 Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase Lichman, Benjamin R. Sula, Altin Pesnot, Thomas Hailes, Helen C. Ward, John M. Keep, Nicholas H. Biochemistry [Image: see text] Norcoclaurine synthase (NCS) is a Pictet-Spenglerase that catalyzes the first key step in plant benzylisoquinoline alkaloid metabolism, a compound family that includes bioactive natural products such as morphine. The enzyme has also shown great potential as a biocatalyst for the formation of chiral isoquinolines. Here we present new high-resolution X-ray crystallography data describing Thalictrum flavum NCS bound to a mechanism-inspired ligand. The structure supports two key features of the NCS “dopamine-first” mechanism: the binding of dopamine catechol to Lys-122 and the position of the carbonyl substrate binding site at the active site entrance. The catalytically vital residue Glu-110 occupies a previously unobserved ligand-bound conformation that may be catalytically significant. The potential roles of inhibitory binding and alternative amino acid conformations in the mechanism have also been revealed. This work significantly advances our understanding of the NCS mechanism and will aid future efforts to engineer the substrate scope and catalytic properties of this useful biocatalyst. American Chemical Society 2017-09-15 2017-10-10 /pmc/articles/PMC5637010/ /pubmed/28915025 http://dx.doi.org/10.1021/acs.biochem.7b00769 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Lichman, Benjamin R.
Sula, Altin
Pesnot, Thomas
Hailes, Helen C.
Ward, John M.
Keep, Nicholas H.
Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase
title Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase
title_full Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase
title_fullStr Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase
title_full_unstemmed Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase
title_short Structural Evidence for the Dopamine-First Mechanism of Norcoclaurine Synthase
title_sort structural evidence for the dopamine-first mechanism of norcoclaurine synthase
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637010/
https://www.ncbi.nlm.nih.gov/pubmed/28915025
http://dx.doi.org/10.1021/acs.biochem.7b00769
work_keys_str_mv AT lichmanbenjaminr structuralevidenceforthedopaminefirstmechanismofnorcoclaurinesynthase
AT sulaaltin structuralevidenceforthedopaminefirstmechanismofnorcoclaurinesynthase
AT pesnotthomas structuralevidenceforthedopaminefirstmechanismofnorcoclaurinesynthase
AT haileshelenc structuralevidenceforthedopaminefirstmechanismofnorcoclaurinesynthase
AT wardjohnm structuralevidenceforthedopaminefirstmechanismofnorcoclaurinesynthase
AT keepnicholash structuralevidenceforthedopaminefirstmechanismofnorcoclaurinesynthase